Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

6.9K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.9K
The Thyroid Gland01:23

The Thyroid Gland

8.8K
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
8.8K
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

9.1K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
9.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Cancer02:18

Cancer

55.9K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.9K
Tumor Progression02:07

Tumor Progression

7.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and Histologic Features of Multifocal Fibrosing Thyroiditis in the Routine Pathology Practice.

Endocrine pathology·2026
Same author

Cribriform morular thyroid carcinoma with EWSR1 gene rearrangement, TERT promoter mutation, and somatic variant of APC.

Virchows Archiv : an international journal of pathology·2026
Same author

How does AI perform compared to human expert panels in medical Delphi studies? A pilot study through the lens of pathology.

Journal of pathology informatics·2026
Same author

The European society of pathology progress test: towards a European external quality control tool for pathology education.

Virchows Archiv : an international journal of pathology·2026
Same author

Artificial intelligence enhances cancer cell selection for HER2 gene amplification assessment in breast carcinoma.

Virchows Archiv : an international journal of pathology·2026
Same author

Multi-center Assessment of DLL3 Expression by Immunohistochemistry in Medullary Thyroid Carcinoma.

Endocrine pathology·2025

Related Experiment Video

Updated: Apr 7, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.4K

Poorly Differentiated and Undifferentiated Thyroid Carcinomas.

Catarina Eloy1, Luciana Ferreira, Catarina Salgado

  • 1Institute of Molecular Pathology and Immunology of the University of Porto, Cancer Biology, Porto, Portugal.

Turk Patoloji Dergisi
|July 16, 2015
PubMed
Summary

Thyroid cancer incidence is rising globally. This review focuses on poorly differentiated (PDTC) and undifferentiated (UTC) thyroid carcinomas, highlighting recent advances in their identification and molecular characterization.

More Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.6K
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.8K

Related Experiment Videos

Last Updated: Apr 7, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.4K
Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
06:08

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

2.6K
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.8K

Area of Science:

  • Endocrinology
  • Oncology
  • Pathology

Background:

  • Thyroid cancer is the most common endocrine malignancy with increasing global incidence.
  • Well-differentiated thyroid carcinomas generally have a good prognosis, unlike aggressive poorly differentiated (PDTC) and undifferentiated (UTC) subtypes.
  • Recent progress has been made in the histologic, immunohistochemical, and molecular identification of PDTC and UTC.

Purpose of the Study:

  • To review recent immunohistochemical and molecular findings in poorly differentiated and undifferentiated thyroid carcinomas.
  • To emphasize the diagnostic and prognostic significance of genetic alterations in these aggressive thyroid cancers.

Main Methods:

  • Literature review of recent studies on PDTC and UTC.
  • Analysis of immunohistochemical and molecular findings.
  • Focus on genetic alterations and their clinical implications.

Main Results:

  • Advances in histologic and immunohistochemical identification of PDTC and UTC.
  • Emerging understanding of molecular characteristics distinguishing these aggressive subtypes.
  • Identification of specific genetic alterations with diagnostic and prognostic value.

Conclusions:

  • Improved diagnostic and prognostic capabilities for PDTC and UTC through molecular and immunohistochemical analysis.
  • Genetic alterations play a crucial role in the progression and lethality of undifferentiated thyroid carcinomas.
  • Further research into molecular mechanisms can guide targeted therapies for aggressive thyroid cancers.